Green Cross Holdings Corporation (005250.KS)
KRW 13460.0
(1.58%)
KRW 13460.0
(1.58%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2057.93 Billion KRW | -1.04% |
| 2022 | 2079.55 Billion KRW | 12.99% |
| 2021 | 1840.55 Billion KRW | 7.05% |
| 2020 | 1719.32 Billion KRW | 12.76% |
| 2019 | 1524.79 Billion KRW | -1.5% |
| 2018 | 1547.97 Billion KRW | 5.67% |
| 2017 | 1464.87 Billion KRW | 8.2% |
| 2016 | 1353.89 Billion KRW | 19.59% |
| 2015 | 1132.11 Billion KRW | 8.46% |
| 2014 | 1043.84 Billion KRW | 11.69% |
| 2013 | 934.62 Billion KRW | 9.27% |
| 2012 | 855.34 Billion KRW | 4.64% |
| 2011 | 817.43 Billion KRW | -1.78% |
| 2010 | 832.29 Billion KRW | 22.35% |
| 2009 | 680.23 Billion KRW | 27.48% |
| 2008 | 533.61 Billion KRW | -15.24% |
| 2007 | 629.53 Billion KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 559.77 Billion KRW | 19.1% |
| 2024 Q1 | 469.99 Billion KRW | -13.22% |
| 2023 Q1 | 438.3 Billion KRW | -13.45% |
| 2023 Q3 | 541.72 Billion KRW | 1.0% |
| 2023 Q2 | 536.34 Billion KRW | 22.37% |
| 2023 Q4 | 541.56 Billion KRW | -0.03% |
| 2023 FY | 2057.93 Billion KRW | -1.04% |
| 2022 Q2 | 517.09 Billion KRW | 2.93% |
| 2022 Q3 | 553.69 Billion KRW | 7.08% |
| 2022 Q4 | 506.39 Billion KRW | -8.54% |
| 2022 Q1 | 502.37 Billion KRW | -0.92% |
| 2022 FY | 2079.55 Billion KRW | 12.99% |
| 2021 Q1 | 345.73 Billion KRW | -31.7% |
| 2021 Q4 | 507.04 Billion KRW | -4.49% |
| 2021 FY | 1840.55 Billion KRW | 7.05% |
| 2021 Q3 | 530.85 Billion KRW | 16.18% |
| 2021 Q2 | 456.91 Billion KRW | 32.16% |
| 2020 Q2 | 418.64 Billion KRW | 16.46% |
| 2020 Q1 | 359.48 Billion KRW | -4.8% |
| 2020 Q3 | 466.21 Billion KRW | 11.36% |
| 2020 FY | 1719.32 Billion KRW | 12.76% |
| 2020 Q4 | 506.22 Billion KRW | 8.58% |
| 2019 Q2 | 384.33 Billion KRW | 9.89% |
| 2019 Q4 | 377.61 Billion KRW | -8.32% |
| 2019 FY | 1524.79 Billion KRW | -1.5% |
| 2019 Q3 | 411.89 Billion KRW | 7.17% |
| 2019 Q1 | 349.73 Billion KRW | -12.22% |
| 2018 Q2 | 407.16 Billion KRW | 18.23% |
| 2018 Q3 | 398 Billion KRW | -2.25% |
| 2018 FY | 1547.97 Billion KRW | 5.67% |
| 2018 Q1 | 344.37 Billion KRW | -6.65% |
| 2018 Q4 | 398.42 Billion KRW | 0.1% |
| 2017 FY | 1464.87 Billion KRW | 8.2% |
| 2017 Q4 | 368.91 Billion KRW | -8.13% |
| 2017 Q3 | 401.56 Billion KRW | 5.96% |
| 2017 Q2 | 378.99 Billion KRW | 20.16% |
| 2017 Q1 | 315.39 Billion KRW | -17.58% |
| 2016 Q1 | 272.57 Billion KRW | -9.25% |
| 2016 Q2 | 343.24 Billion KRW | 25.93% |
| 2016 Q3 | 355.41 Billion KRW | 3.55% |
| 2016 Q4 | 382.65 Billion KRW | 7.67% |
| 2016 FY | 1353.89 Billion KRW | 19.59% |
| 2015 FY | 1132.11 Billion KRW | 8.46% |
| 2015 Q4 | 300.34 Billion KRW | -2.44% |
| 2015 Q3 | 307.85 Billion KRW | 6.73% |
| 2015 Q2 | 288.43 Billion KRW | 22.48% |
| 2015 Q1 | 235.48 Billion KRW | -14.07% |
| 2014 FY | 1043.84 Billion KRW | 11.69% |
| 2014 Q3 | 294.78 Billion KRW | 16.86% |
| 2014 Q2 | 252.25 Billion KRW | 13.24% |
| 2014 Q1 | 222.76 Billion KRW | -14.15% |
| 2014 Q4 | 274.03 Billion KRW | -7.04% |
| 2013 Q4 | 259.46 Billion KRW | -4.15% |
| 2013 FY | 934.62 Billion KRW | 9.27% |
| 2013 Q1 | 186.62 Billion KRW | -8.35% |
| 2013 Q2 | 217.84 Billion KRW | 16.73% |
| 2013 Q3 | 270.68 Billion KRW | 24.25% |
| 2012 Q3 | 250.58 Billion KRW | 16.68% |
| 2012 Q2 | 214.76 Billion KRW | 15.24% |
| 2012 Q1 | 186.36 Billion KRW | 131.63% |
| 2012 FY | 855.34 Billion KRW | 4.64% |
| 2012 Q4 | 203.64 Billion KRW | -18.73% |
| 2011 Q1 | 167.47 Billion KRW | 0.0% |
| 2011 Q3 | 517.47 Billion KRW | 155.71% |
| 2011 Q4 | -589.14 Billion KRW | -213.85% |
| 2011 Q2 | 202.36 Billion KRW | 20.84% |
| 2011 FY | 817.43 Billion KRW | -1.78% |
| 2010 Q2 | 5.24 Billion KRW | -30.93% |
| 2010 Q3 | 5.91 Billion KRW | 12.65% |
| 2010 FY | 832.29 Billion KRW | 22.35% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q1 | 7.59 Billion KRW | 0.0% |
| 2009 Q3 | 5.09 Billion KRW | 8.9% |
| 2009 Q2 | 4.67 Billion KRW | 8.3% |
| 2009 Q1 | 4.31 Billion KRW | 0.0% |
| 2009 FY | 680.23 Billion KRW | 27.48% |
| 2009 Q4 | - KRW | -100.0% |
| 2008 Q3 | 5.04 Billion KRW | 9.3% |
| 2008 Q2 | 4.61 Billion KRW | 1.55% |
| 2008 Q1 | 4.54 Billion KRW | 0.0% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 FY | 533.61 Billion KRW | -15.24% |
| 2007 Q1 | 4.23 Billion KRW | 0.0% |
| 2007 FY | 629.53 Billion KRW | 0.0% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 Q2 | 4.58 Billion KRW | 8.23% |
| 2007 Q3 | 5.29 Billion KRW | 15.33% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ORIENT BIO Inc. | 28 Billion KRW | -7248.425% |
| Green Cross Holdings Corporation | 1626.64 Billion KRW | -26.514% |
| Pharmicell Co., Ltd. | 56.22 Billion KRW | -3560.024% |
| Green Cross Corporation | 1626.64 Billion KRW | -26.514% |
| GeneOne Life Science, Inc. | 40.2 Billion KRW | -5018.872% |
| Celltrion, Inc. | 2176.43 Billion KRW | 5.445% |
| Samsung Biologics Co.,Ltd. | 3694.58 Billion KRW | 44.299% |
| SK bioscience Co.,Ltd. | 369.5 Billion KRW | -456.943% |
| SK Biopharmaceuticals Co., Ltd. | 354.89 Billion KRW | -479.877% |
| Prestige BioPharma Limited | 689.07 Million KRW | -298551.918% |